Zhongda'an: Wu Junye, the controlling shareholder, plans to reduce his holdings by no more than 2%

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

Unpacking China | Key Chinese Firms to Watch This Week （24/05/2026-30/05/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

CHAGEE (霸王茶姬) Q1 Overseas GMV Surges 139% YoY as Global Expansion Enters Acceleration Phase

CHAGEE (霸王茶姬) recorded a 139% YoY surge in overseas GMV to 426 million RMB in Q1 2026, driven by an expanded network of 374 outlets across Southeast Asia and East Asia alongside localized operational adaptations.

Xiaomi EV (小米汽车) Anticipates Official Global Launch in the Second Half of 2027

Xiaomi EV (小米汽车) plans to officially launch its overseas expansion in the second half of 2027, adopting an unconventional strategy that targets developed, right-hand drive, and mid-to-high-end markets first to directly challenge global luxury auto giants.

GAC Group (广汽集团) Releases Global Expansion Report Card: 2025 Exports Exceed 130,000 Units, Setting an Aggressive Growth Target of 250,000 Units for 2026

GAC Group (广汽集团) achieved a historic milestone with over 130,000 overseas units sold in 2025 (up 45% YoY), and has set an aggressive target of 250,000 units for 2026 driven by its "Xingyuan Range Extender" technology and localized KD manufacturing across global markets.